FDA-Recommended Primary Endpoint for HIV Switch Trials
Evidence Supporting 48-Week Endpoint
- The FDA recommends checking viral load 1 month after switching to ensure initial maintenance of suppression, but this does not constitute the primary efficacy endpoint, according to guidelines from the American Medical Association, as reported in JAMA 1, 2